Myoepithelial cells lining milk ducts hold key to spread of DCIS

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 5
Volume 17
Issue 5

Researchers at Dana-Farber have found that normal myoepithelial cells, which form part of the lining of the milk ducts, suppress fibroblasts that promote tumor growth and invasion, but when certain genes in the myoepithelial layer become under- or overactive, the layer breaks down and disappears, enabling tumor cells to spread.

Researchers at Dana-Farber have found that normal myoepithelial cells, which form part of the lining of the milk ducts, suppress fibroblasts that promote tumor growth and invasion, but when certain genes in the myoepithelial layer become under- or overactive, the layer breaks down and disappears, enabling tumor cells to spread. The abnormal genes include TGF Beta, Hedgehog, and p63. The study was reported in the May 6 issue of Cancer Cell.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
Related Content